Avita Medical, Inc. short interest in 2023
In 2023, Avita Medical, Inc.'s disclosed short interest ran from 1.44% of shares outstanding on 13 Jan 2023 to 2.29% on 29 Dec 2023, a change of +0.85 percentage points. The year's high was 5.02% on 14 Jul 2023 and its low 1.44% on 13 Jan 2023, averaging 2.73% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.09 days on 31 Aug 2023. Full history: Avita Medical, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 1.44% (13 Jan 2023)
- End of year
- 2.29% (29 Dec 2023)
- Change
- +0.85 pp
- High
- 5.02% (14 Jul 2023)
- Low
- 1.44% (13 Jan 2023)
- Average
- 2.73%
- Highest days to cover
- 9.09 (31 Aug 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 1.44% | 5.71 | |
| 31 Jan 2023 | 1.66% | 3.82 | |
| 15 Feb 2023 | 1.76% | 4.57 | |
| 28 Feb 2023 | 2.48% | 2.20 | 10-K filed |
| 15 Mar 2023 | 2.67% | 3.55 | |
| 31 Mar 2023 | 2.30% | 4.28 | |
| 14 Apr 2023 | 2.78% | 3.84 | |
| 28 Apr 2023 | 2.16% | 2.77 | |
| 15 May 2023 | 1.83% | 1.81 | 10-Q filed, results (8-K) |
| 31 May 2023 | 1.96% | 3.00 | |
| 15 Jun 2023 | 2.21% | 1.94 | |
| 30 Jun 2023 | 4.65% | 2.00 | |
| 14 Jul 2023 | 5.02% | 4.16 | |
| 31 Jul 2023 | 3.82% | 4.77 | |
| 15 Aug 2023 | 3.62% | 5.07 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 3.67% | 9.09 | |
| 15 Sep 2023 | 3.68% | 8.82 | |
| 29 Sep 2023 | 3.57% | 8.31 | |
| 13 Oct 2023 | 2.87% | 2.20 | |
| 31 Oct 2023 | 2.29% | 3.68 | results (8-K) |
| 15 Nov 2023 | 2.44% | 3.23 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 2.32% | 2.83 | |
| 15 Dec 2023 | 2.00% | 3.82 | |
| 29 Dec 2023 | 2.29% | 4.67 |
See also: Avita Medical, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.